[ad_1]
Centogene NV (NASDAQ: CNTG) shares fell 2.74%, or $ 0.2865 per share, to close at $ 10.16 on Wednesday. When the day opened at $ 10.27, Centogene NV’s shares moved between $ 10.53 and $ 10.02. 20,850 shares traded compared to the 30-day average of 17,586. Wednesday’s activity brought Centogene NV’s market cap to $ 224,715,253.
Centogene NV is headquartered in Rostock, Mecklenburg-Western Pomerania.
About Centogene NV
CENTOGENE is engaged in the diagnosis and research of rare diseases, converting real clinical and genetic data into actionable information for patients, doctors and pharmaceutical companies. Her goal is to rationalize treatment decisions and accelerate the development of new orphan drugs by leveraging her extensive knowledge of rare diseases, including epidemiological and clinical data, as well as innovative biomarkers. CENTOGENE has developed a global proprietary platform for rare diseases based on its real data archive with over 3.6 billion weighted data points from around 595,000 patients from over 120 different countries (as of September 30, 2020). The company’s platform includes epidemiological, phenotypic and genetic data reflecting a world population, as well as a biobank of blood samples from these patients. CENTOGENE believes this is the only platform that fully analyzes multi-tiered data to improve understanding of rare hereditary diseases, which can help identify patients and improve the ability of its pharmaceutical partners to bring orphan drugs to market. As of September 30, 2020, the company worked with over 40 pharmaceutical partners covering over 45 different rare diseases.
Visit the Centogene NV profile for more information.
Via the Nasdaq Stock Exchange
The Nasdaq Stock Market is a leading global provider of trading data and services, as well as the listing of stocks and options. Nasdaq is the world’s leading exchange for option volumes and is home to the five largest US companies – Apple, Microsoft, Amazon, Alphabet and Facebook.
For more information about Centogene NV and to keep up with the latest company updates, please visit the company’s profile page here: Centogene NV Profile. For more news on the financial markets, see Equities News. Don’t forget either Registration for the Daily Fix to get the best stories to your inbox 5 days a week.
Sources: The chart is provided by TradingView based on 15 minute delayed prices. All other data will be provided by IEX Cloud starting at 8:05 p.m. ET on the day of publication.
DISCLOSURE:
The views and opinions expressed in this article are those of the authors and do not reflect the views of equities.com. Readers should not regard statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer
Beyond Meat launches meat-free chicken offerings in grocery stores in October
President Biden welcomes leaders from India, Japan and Australia to the first “Quad†summit on Friday
Some Chinese banks are no longer providing new loans to real estate developers amid fears of Evergrande
Iowa Senator Chuck Grassley is seeking eighth term
House Special Committee summons for four Trump allies in the U.S. Capitol Riot rehearsal
CDC Endorses COVID-19 Vaccine Booster Vaccinations for Millions of Elderly and Vulnerable People
Semiconductor shortages will cost the global auto industry $ 210 billion in sales in 2021
U.S. Olympic athletes must be vaccinated against COVID-19 for the Beijing Winter Games
[ad_2]
